Restoration of NET formation by gene therapy in CGD controls aspergillosis
- PMID: 19541821
- PMCID: PMC2756123
- DOI: 10.1182/blood-2009-05-221606
Restoration of NET formation by gene therapy in CGD controls aspergillosis
Abstract
Chronic granulomatous disease (CGD) patients have impaired nicotinamide adenine dinucleotide phosphate (NADPH) oxidase function, resulting in poor antimicrobial activity of neutrophils, including the inability to generate neutrophil extracellular traps (NETs). Invasive aspergillosis is the leading cause of death in patients with CGD; it is unclear how neutrophils control Aspergillus species in healthy persons. The aim of this study was to determine whether gene therapy restores NET formation in CGD by complementation of NADPH oxidase function, and whether NETs have antimicrobial activity against Aspergillus nidulans. Here we show that reconstitution of NET formation by gene therapy in a patient with CGD restores neutrophil elimination of A nidulans conidia and hyphae and is associated with rapid cure of preexisting therapy refractory invasive pulmonary aspergillosis, underlining the role of functional NADPH oxidase in NET formation and antifungal activity.
Figures
Comment in
-
Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD).Blood. 2009 Oct 15;114(16):3497; author reply 3498. doi: 10.1182/blood-2009-07-233312. Blood. 2009. PMID: 19833851 Free PMC article. No abstract available.
Similar articles
-
Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD).Blood. 2009 Oct 15;114(16):3497; author reply 3498. doi: 10.1182/blood-2009-07-233312. Blood. 2009. PMID: 19833851 Free PMC article. No abstract available.
-
Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7. doi: 10.1016/j.jaci.2011.01.021. Epub 2011 Mar 3. J Allergy Clin Immunol. 2011. PMID: 21376380
-
Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease.Trans Am Clin Climatol Assoc. 2007;118:175-85. Trans Am Clin Climatol Assoc. 2007. PMID: 18528501 Free PMC article. Review.
-
Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.mBio. 2018 Mar 27;9(2):e00422-18. doi: 10.1128/mBio.00422-18. mBio. 2018. PMID: 29588403 Free PMC article.
-
Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction.J Infect Dis. 2012 Oct 1;206(7):1128-37. doi: 10.1093/infdis/jis473. Epub 2012 Jul 24. J Infect Dis. 2012. PMID: 22829648 Review.
Cited by
-
Histone H3 clipping is a novel signature of human neutrophil extracellular traps.Elife. 2022 Oct 25;11:e68283. doi: 10.7554/eLife.68283. Elife. 2022. PMID: 36282064 Free PMC article.
-
Gene therapy for PIDs: progress, pitfalls and prospects.Gene. 2013 Aug 10;525(2):174-81. doi: 10.1016/j.gene.2013.03.098. Epub 2013 Apr 6. Gene. 2013. PMID: 23566838 Free PMC article. Review.
-
The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.Int J Mol Sci. 2021 May 20;22(10):5368. doi: 10.3390/ijms22105368. Int J Mol Sci. 2021. PMID: 34065210 Free PMC article. Review.
-
Chronic granulomatous disease.Hematol Oncol Clin North Am. 2013 Feb;27(1):89-99, viii. doi: 10.1016/j.hoc.2012.11.002. Epub 2012 Nov 22. Hematol Oncol Clin North Am. 2013. PMID: 23351990 Free PMC article. Review.
-
Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense.PLoS One. 2011;6(12):e28149. doi: 10.1371/journal.pone.0028149. Epub 2011 Dec 7. PLoS One. 2011. PMID: 22163282 Free PMC article.
References
-
- Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–1535. - PubMed
-
- Urban CF, Reichard U, Brinkmann V, Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 2006;8:668–676. - PubMed
-
- Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140:255–266. - PubMed
-
- Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998;77:345–354. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical